BUND FINANCE › Stocks › MCK
McKesson Corporation (MCK)
NYSE · Stock price, chart and technical analysis
Data from Financial Modeling Prep · Nov 18, 2026, 4:00 PM New York time · may be delayed
Key stats
Quick technical read
- Price is +12.60% above its 50-day average.
- It is +23.67% above its 200-day average (long-term uptrend).
- It sits at 91% of its 52-week range (0% = low, 100% = high).
This describes price action; it is not a recommendation. The app also calculates RSI, MACD, the entry setup and 30+ indicators. How we calculate it
Fundamentals Annual
| Fiscal year | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | US$264.0B | US$276.7B | US$309.0B | US$359.1B | US$403.4B |
| Net income | US$1.1B | US$3.6B | US$3.0B | US$3.3B | US$4.8B |
| EPS (diluted) | 7.23 | 25.04 | 22.39 | 25.72 | 38.38 |
| Gross margin | 4.8% | 4.3% | 4.0% | 3.5% | 3.6% |
| Operating margin | 1.0% | 1.6% | 1.3% | 1.2% | 1.6% |
| Net margin | 0.4% | 1.3% | 1.0% | 0.9% | 1.2% |
| Free cash flow | US$3.9B | US$4.6B | US$3.6B | US$5.2B | US$5.4B |
| Total debt | US$7.5B | US$7.3B | US$7.4B | US$7.4B | US$8.6B |
| Cash | US$3.5B | US$4.7B | US$4.6B | US$5.7B | US$4.0B |
Compound annual growth: revenue 11.2% · net income 43.8% (4 years).
Valuation: today, its history and its sector
| Today | 5-year average | Sector median (Healthcare) | |
|---|---|---|---|
| P/E | 27.9x | 25.7x | 27.1x |
| EV / EBITDA | 17.2x | 15.1x | 16.5x |
| Operating margin | 1.6% | — | 3.6% |
| Net margin | 1.1% | — | -0.0% |
| Debt / equity | — | — | 0.58 |
Source: annual financial statements from Financial Modeling Prep. “Today” uses the current price and the last 4 quarters. The sector median uses U.S. companies above US$300M market cap. A multiple above or below its history or sector is not a recommendation.
About McKesson Corporation
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader busin…
Other stocks on BUND FINANCE
Not financial advice. BUND FINANCE publishes general information for educational purposes. Investing involves risk, including loss of capital. Legal notice